FRIDAY, May 13, 2022 (HealthDay News) — An experimental gene therapy for spinal cord pain shows promise in mice, researchers say. About half of spinal cord injury patients have neuropathy, which is chronic or debilitating pain, tingling, numbness or muscle weakness caused by damaged or malfunctioning nerves. Treatment of neuropathyContinue Reading